# Autologous Bone Marrow-Derived Stem Cell Transplantation in Patients With Premature Ovarian Failure (POF)

> **NCT03069209** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Stem Cells Arabia** · enrollment: 50 (estimated)

## Conditions studied

- Premature Ovarian Failure

## Interventions

- **BIOLOGICAL:** Stem Cells

## Key facts

- **NCT ID:** NCT03069209
- **Lead sponsor:** Stem Cells Arabia
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2021-06
- **Final completion:** 2022-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2018-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03069209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03069209, "Autologous Bone Marrow-Derived Stem Cell Transplantation in Patients With Premature Ovarian Failure (POF)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03069209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*